Navlimetostat (hydrochloride)

Produktübersicht

• Artikelname: Navlimetostat (hydrochloride)
• Artikelnummer: MCE-HY-139611C
• Hersteller Artikelnummer: HY-139611C
• Alternativnummer: MCE-HY-139611C-5MG,MCE-HY-139611C-25MG,MCE-HY-139611C-10MG,MCE-HY-139611C-100MG,MCE-HY-139611C-10MMX1ML,MCE-HY-139611C-50MG,MCE-HY-139611C-1MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: MRTX-1719 (hydrochloride), BMS-986504 (hydrochloride)

Produktbeschreibung

Navlimetostat hydrochloride is a potent, orally active, selective PRMT5-MTA complex inhibitor, with IC50s of 3.6 and 20.5 nM for PRMT5-MTA and PRMT5. Navlimetostat hydrochloride binds to the PRMT5-MTA complex, with KD value of 0.14 pM. Navlimetostat shows antineoplastic activity in vitro and in vivo, and can be used for cancer study[1][2].

Produkteigenschaften

• Molekulargewicht: 501.34
• Reinheit: 99.61
• Formel: C23H19Cl2FN6O2
• Target-Kategorie: Histone Methyltransferase

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound